West China Hospital of Sichuan University
Chengdu, Sichuan, China
NCT Number: NCT07670403
This prospective observational study enrolls 500 skin cancer patients across five Chinese tertiary care centers. The investigators use natural language processing and a hierarchical transformer model to analyse 1.2 million social media posts (Weibo, Douyin, Xiaohongshu, WeChat) for psychological distress and suicide ideation, with prospective validation of an AI Early Warning System.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Chengdu, Sichuan, China
Skin cancer patients experience high rates of anxiety and depression, yet routine screening is inconsistent. This study collects social media content from 500 patients over 24 months (12 months retrospective + 12 months prospective). Linguistic markers are identified using a custom Skin Cancer Linguistic Inquiry and Word Count (SC-LIWC) dictionary developed through expert consensus. A hierarchical transformer network with multi-head self-attention is built, comprising word-level (RoBERTa-wwm-ext), post-level (BiGRU+attention), and user-level (8-head self-attention) encoders with platform embeddings to address cross-platform heterogeneity. The model predicts suicide ideation risk (C-SSRS score ≥2) within 12 months, achieving AUC=0.91 in validation. An AI Early Warning System (EWS) is prospectively tested: alerts are triggered at threshold 0.38, reviewed by psychologists (12.4 min/alert), and interventions (crisis hotline, online counselling, psychoeducational materials) are automatically delivered. All data collection complies with China's Personal Information Protection Law (PIPL) and uses a 5-layer de-identification protocol (direct identifier removal, SHA-256 hashing, NER redaction, timestamp shifting, role-based access control). The study also examines cross-platform performance, optimal observation windows, and false-positive patterns to guide refinement
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 24 months
Proportion of participants with C-SSRS score ≥ 2 (active suicidal ideation with some intent to act, without specific plan) at any follow-up assessment. The C-SSRS is a clinician-administered instrument with a severity subscale ranging from 0 (no suicidal ideation) to 5 (active suicidal ideation with specific plan and intent). Higher scores indicate greater suicide risk.
Time frame: 24 months
Mean change in PHQ-9 total score from baseline to each follow-up assessment. The PHQ-9 is a 9-item self-report questionnaire measuring depressive symptoms over the past 2 weeks. Total scores range from 0 to 27, with higher scores indicating greater depression severity (moderate-to-severe: ≥10).
Time frame: 24 months
Mean change in GAD-7 total score from baseline to each follow-up assessment. The GAD-7 is a 7-item self-report questionnaire measuring generalized anxiety symptoms over the past 2 weeks. Total scores range from 0 to 21, with higher scores indicating greater anxiety severity (moderate-to-severe: ≥10).
Time frame: 24 months
Mean change in HADS total score (sum of Anxiety and Depression subscales) from baseline to each follow-up assessment. The HADS is a 14-item self-report questionnaire with two 7-item subscales (Anxiety and Depression), each ranging from 0 to 21. Higher subscale scores indicate worse psychological distress (subscale ≥15 indicates clinically significant distress).
Time frame: 24 months
Proportion of high-risk participants (C-SSRS ≥ 2) who access at least one psychological resource (crisis hotline, online counseling link, or psychoeducational material) following an automated alert from the AI Early Warning System, compared to a matched historical control group (pre-EWS period).
West China Hospital
Other
Digital Phenotyping of Psychological Distress in Skin Cancer Patients: A Transformer-Based Analysis of Chinese Social Media Content
Acronym: DP-SKIN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05520099
Adenocarcinoma, Bladder Cancer
Little Rock, Arkansas, United States
View Trial DetailsNCT06608511
Basal Cell Carcinoma of Skin, Basal Cell Carcinoma of Skin, Site Unspecified
Madison, Wisconsin, United States
View Trial DetailsNCT07327489
Advanced Solid Tumors Cancer, Bladder Cancer
Fort Smith, Arkansas, United States
View Trial DetailsNCT05086692
Acral Melanoma, Adenocarcinoma
San Diego, California, United States
View Trial Details